Claims for Patent: 10,011,856
✉ Email this page to a colleague
Summary for Patent: 10,011,856
Title: | Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase |
Abstract: | The present invention provides methods and compositions for reducing lactate production and increasing polypeptide production in cultured cells. In one aspect, the invention provides a method comprising culturing cells expressing a) a small interfering RNA (siRNA) specific for a lactate dehydrogenase (LDH) and b) an siRNA specific for a pyruvate dehydrogenase kinase (PDHK). In another aspect, the invention provides cultured cells or vectors comprising an siRNA specific for a LDH and an siRNA specific for a PDHK. |
Inventor(s): | Zhou Meixia, Snedecor Bradley Richard, Ng Chi Kin Domingos, Shen Amy |
Assignee: | Genentech, Inc. |
Application Number: | US15268424 |
Details for Patent 10,011,856
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | February 26, 2004 | 10,011,856 | 2036-09-16 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |